Asperger Disorder
7
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
28.6%
2 terminated out of 7 trials
60.0%
-26.6% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
Pediatric Patients With Metabolic or Other Genetic Disorders
QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)
Understanding the Effects of Intervention on the Brain in Autism
Cholesterol in ASD: Characterization and Treatment
Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders